论文部分内容阅读
目的评价徒手心肺复苏法(CPR)+体外无创心脏起博(NP)+经静脉临时心脏起博三者有机结合抢救心脏骤停患者的价值。方法将95例心脏骤停患者随机分成3组,即对照组1(CRP+NP组)30例;对照组2(CRP+经静脉临时心脏起博组)30例;治疗组(CRP+NP+经静脉临时心脏起博)35例。治疗组在基础治疗的基础上,进行分组治疗。分别记录三组患者抢救成功率,然后进行组间比较。结果治疗组35例中有32例(91.4%)复苏成功;对照组1中有16例(53.3%)复苏成功;对照组2中有19例(63.3%)复苏成功。结论 CRP和NP联合经静脉临时心脏起博是治疗心脏骤停的最佳方法,具有重要的临床价值和意义。
Objective To evaluate the value of CPR + NP in vitro + temporary cardiac pacing in patients undergoing cardiac arrest combined with organic cardiopulmonary bypass. Methods Ninety-five patients with cardiac arrest were randomly divided into three groups: control group 1 (CRP + NP group), control group 2 (CRP + transcatheter arterial cardioplegia group), and treatment group (CRP + NP + Temporary cardioplegia) 35 cases. Treatment group based on the basic treatment, group treatment. Three groups were recorded rescue success rate, and then compared between groups. RESULTS: Thirty-two (91.4%) of the 35 patients in the treatment group recovered successfully; 16 (53.3%) patients in control group 1 recovered successfully; and 19 (63.3%) patients in control group 2 recovered successfully. Conclusions The combination of CRP and NP via transvenous temporary cardioversion is the best method to treat cardiac arrest and has important clinical value and significance.